APO Research
Talk to an analyst

APO RESEARCH · REPORT

Influenza Vaccine

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Selected research

Industry Growth & Trends

Global Influenza Vaccine Industry Growth and Trends Forecast to 2032

21 December 202592 pages

Choose your research edition.

Industry ResearchInfluenza Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza Vaccine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Global Influenza Vaccine main players include CSL, GSK, Sanofi Pasteur, Mylan, Hulan Bio, AstraZeneca, CCBIO, etc., totally accounting for about 95% of market. North America is the largest market of Influenza Vaccine, with a share over 55%. As for the types of products, it can be divided into Trivalent Influenza Vaccine and Quadrivalent Influenza Vaccine. The most common product is Quadrivalent Influenza Vaccine, with a share over 95%. In terms of applications, it is widely used in For Children (6 months to 3 years) and For Adults and Children over 3 years. The most application is in Adults and Children over 3 years, with a share over 73%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Influenza Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Influenza Vaccine market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Influenza Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Influenza Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Influenza Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Influenza Vaccine Market by Company

CSL

GSK

Sanofi Pasteur

Mylan

Hulan Bio

AstraZeneca

CCBIO

Influenza Vaccine Segment by Type

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

Influenza Vaccine Segment by Application

For Children (6 months to 3 years)

For Adults and Children over 3 years

Influenza Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Influenza Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Trivalent Influenza Vaccine Table 2. Major Company of Quadrivalent Influenza Vaccine Table 3. Global Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Influenza Vaccine Sales by Type (2021-2026) & (M Doses) Table 5. Global Influenza Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Influenza Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Influenza Vaccine Price by Type (2021-2026) & (USD/Doses) Table 9. Global Influenza Vaccine Sales by Type (2027-2032) & (M Doses) Table 10. Global Influenza Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Influenza Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Influenza Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Influenza Vaccine Price by Type (2027-2032) & (USD/Doses) Table 14. North America Influenza Vaccine Sales by Type (2021-2026) & (M Doses) Table 15. North America Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Influenza Vaccine Sales by Type (2021-2026) & (M Doses) Table 17. Europe Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Influenza Vaccine Sales by Type (2021-2026) & (M Doses) Table 19. Asia-Pacific Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Influenza Vaccine Sales by Type (2021-2026) & (M Doses) Table 21. Latin America Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Influenza Vaccine Sales by Type (2021-2026) & (M Doses) Table 23. Middle East and Africa Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Influenza Vaccine Industry Trends Table 25. Influenza Vaccine Industry Drivers Table 26. Influenza Vaccine Industry Opportunities and Challenges Table 27. Influenza Vaccine Industry Restraints Table 28. Global Influenza Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Influenza Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Influenza Vaccine Sales by Company (2021-2026) & (M Doses) Table 31. Global Influenza Vaccine Sales Share by Company (2021-2026) Table 32. Global Influenza Vaccine Market Price by Company (2021-2026) & (USD/Doses) Table 33. Global Influenza Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Influenza Vaccine Major Company Production Sites and Headquarters Table 35. Global Influenza Vaccine Company, Product Type & Application Table 36. Global Influenza Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Influenza Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Influenza Vaccine Sales by Region (2021-2026) & (M Doses) Table 41. Global Influenza Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Influenza Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Influenza Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Influenza Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 45. Global Influenza Vaccine Sales by Region (2027-2032) & (M Doses) Table 46. Global Influenza Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Influenza Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Influenza Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Influenza Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2027-2032) Table 50. Global Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Influenza Vaccine Sales by Application (2021-2026) & (M Doses) Table 52. Global Influenza Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Influenza Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Influenza Vaccine Price by Application (2021-2026) & (USD/Doses) Table 56. Global Influenza Vaccine Sales by Application (2027-2032) & (M Doses) Table 57. Global Influenza Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Influenza Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Influenza Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Influenza Vaccine Price by Application (2027-2032) & (USD/Doses) Table 61. North America Influenza Vaccine Sales by Application (2021-2026) & (M Doses) Table 62. North America Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Influenza Vaccine Sales by Application (2021-2026) & (M Doses) Table 64. Europe Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Influenza Vaccine Sales by Application (2021-2026) & (M Doses) Table 66. Asia-Pacific Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Influenza Vaccine Sales by Application (2021-2026) & (M Doses) Table 68. Latin America Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Influenza Vaccine Sales by Application (2021-2026) & (M Doses) Table 70. Middle East and Africa Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. CSL Company Information Table 72. CSL Business Overview Table 73. CSL Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 74. CSL Influenza Vaccine Product Portfolio Table 75. CSL Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 79. GSK Influenza Vaccine Product Portfolio Table 80. GSK Recent Development Table 81. Sanofi Pasteur Company Information Table 82. Sanofi Pasteur Business Overview Table 83. Sanofi Pasteur Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 84. Sanofi Pasteur Influenza Vaccine Product Portfolio Table 85. Sanofi Pasteur Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 89. Mylan Influenza Vaccine Product Portfolio Table 90. Mylan Recent Development Table 91. Hulan Bio Company Information Table 92. Hulan Bio Business Overview Table 93. Hulan Bio Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 94. Hulan Bio Influenza Vaccine Product Portfolio Table 95. Hulan Bio Recent Development Table 96. AstraZeneca Company Information Table 97. AstraZeneca Business Overview Table 98. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 99. AstraZeneca Influenza Vaccine Product Portfolio Table 100. AstraZeneca Recent Development Table 101. CCBIO Company Information Table 102. CCBIO Business Overview Table 103. CCBIO Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 104. CCBIO Influenza Vaccine Product Portfolio Table 105. CCBIO Recent Development Table 106. North America Influenza Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 107. North America Influenza Vaccine Sales by Country (2021-2026) & (M Doses) Table 108. North America Influenza Vaccine Sales Market Share by Country (2021-2026) Table 109. North America Influenza Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 110. North America Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. North America Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Influenza Vaccine Market Share by Country (2021-2026) Table 114. North America Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 116. Europe Influenza Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 117. Europe Influenza Vaccine Sales by Country (2021-2026) & (M Doses) Table 118. Europe Influenza Vaccine Sales Market Share by Country (2021-2026) Table 119. Europe Influenza Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 120. Europe Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Influenza Vaccine Market Share by Country (2021-2026) Table 124. Europe Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Influenza Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Influenza Vaccine Sales by Country (2021-2026) & (M Doses) Table 128. Asia-Pacific Influenza Vaccine Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Influenza Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 130. Asia-Pacific Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Influenza Vaccine Market Share by Country (2021-2026) Table 134. Asia-Pacific Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 136. Latin America Influenza Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 137. Latin America Influenza Vaccine Sales by Country (2021-2026) & (M Doses) Table 138. Latin America Influenza Vaccine Sales Market Share by Country (2021-2026) Table 139. Latin America Influenza Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 140. Latin America Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Influenza Vaccine Market Share by Country (2021-2026) Table 144. Latin America Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Influenza Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Influenza Vaccine Sales by Country (2021-2026) & (M Doses) Table 148. Middle East and Africa Influenza Vaccine Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Influenza Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 150. Middle East and Africa Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Influenza Vaccine Market Share by Country (2021-2026) Table 154. Middle East and Africa Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Influenza Vaccine Distributors List Table 159. Influenza Vaccine Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Influenza Vaccine Image Figure 2. Global Influenza Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Influenza Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Influenza Vaccine Sales (2021-2032) & (M Doses) Figure 5. Trivalent Influenza Vaccine Image Figure 6. Global Trivalent Influenza Vaccine Sales YoY Growth (2021-2032) & (M Doses) Figure 7. Quadrivalent Influenza Vaccine Image Figure 8. Global Quadrivalent Influenza Vaccine Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Global Influenza Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Influenza Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Influenza Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. For Children (6 months to 3 years) Image Figure 24. Global For Children (6 months to 3 years) Sales YoY Growth (2021-2032) & (M Doses) Figure 25. For Adults and Children over 3 years Image Figure 26. Global For Adults and Children over 3 years Sales YoY Growth (2021-2032) & (M Doses) Figure 27. Global Influenza Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Influenza Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 40. North America Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 44. Europe Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 48. Asia-Pacific Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 52. Latin America Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 56. Middle East and Africa Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Influenza Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Influenza Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Trivalent Influenza Vaccine
  • Quadrivalent Influenza Vaccine
Applications
  • For Children (6 months to 3 years)
  • For Adults and Children over 3 years
Companies covered
  • CSL
  • GSK
  • Sanofi Pasteur
  • Mylan
  • Hulan Bio
  • AstraZeneca
  • CCBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Influenza Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Influenza Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Influenza Vaccine Market by Type
  6. 1.3.1 Trivalent Influenza Vaccine
  7. 1.3.2 Quadrivalent Influenza Vaccine
  8. 1.4 Global Influenza Vaccine Market Size by Type
  9. 1.4.1 Global Influenza Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Influenza Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Influenza Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Influenza Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Influenza Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Influenza Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Influenza Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Influenza Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Influenza Vaccine Industry Trends
  2. 2.2 Influenza Vaccine Industry Drivers
  3. 2.3 Influenza Vaccine Industry Opportunities and Challenges
  4. 2.4 Influenza Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Influenza Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Influenza Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Influenza Vaccine Price (2021-2026)
  4. 3.4 Global Influenza Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Influenza Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Influenza Vaccine Company, Product Type & Application
  7. 3.7 Global Influenza Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Influenza Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Influenza Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Influenza Vaccine Tier 1, Tier 2, and Tier 3
4 Influenza Vaccine Regional Status and Outlook
  1. 4.1 Global Influenza Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Influenza Vaccine Historic Market Size by Region
  3. 4.2.1 Global Influenza Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Influenza Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Influenza Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Influenza Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Influenza Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Influenza Vaccine by Application
  1. 5.1 Influenza Vaccine Market by Application
  2. 5.1.1 For Children (6 months to 3 years)
  3. 5.1.2 For Adults and Children over 3 years
  4. 5.2 Global Influenza Vaccine Market Size by Application
  5. 5.2.1 Global Influenza Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Influenza Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Influenza Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Influenza Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Influenza Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Influenza Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Influenza Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Influenza Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSL
  2. 6.1.1 CSL Company Information
  3. 6.1.2 CSL Business Overview
  4. 6.1.3 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSL Influenza Vaccine Product Portfolio
  6. 6.1.5 CSL Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Influenza Vaccine Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Sanofi Pasteur
  14. 6.3.1 Sanofi Pasteur Company Information
  15. 6.3.2 Sanofi Pasteur Business Overview
  16. 6.3.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Pasteur Influenza Vaccine Product Portfolio
  18. 6.3.5 Sanofi Pasteur Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Influenza Vaccine Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Hulan Bio
  26. 6.5.1 Hulan Bio Company Information
  27. 6.5.2 Hulan Bio Business Overview
  28. 6.5.3 Hulan Bio Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hulan Bio Influenza Vaccine Product Portfolio
  30. 6.5.5 Hulan Bio Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Influenza Vaccine Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 CCBIO
  38. 6.7.1 CCBIO Company Information
  39. 6.7.2 CCBIO Business Overview
  40. 6.7.3 CCBIO Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CCBIO Influenza Vaccine Product Portfolio
  42. 6.7.5 CCBIO Recent Developments
7 North America by Country
  1. 7.1 North America Influenza Vaccine Sales by Country
  2. 7.1.1 North America Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Influenza Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Influenza Vaccine Market Size by Country
  6. 7.2.1 North America Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Influenza Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Influenza Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Influenza Vaccine Sales by Country
  2. 8.1.1 Europe Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Influenza Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Influenza Vaccine Market Size by Country
  6. 8.2.1 Europe Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Influenza Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Influenza Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Influenza Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Influenza Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Influenza Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Influenza Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Influenza Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Influenza Vaccine Sales by Country
  2. 10.1.1 South America Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Influenza Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Influenza Vaccine Market Size by Country
  6. 10.2.1 South America Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Influenza Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Influenza Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Influenza Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Influenza Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Influenza Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Influenza Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Influenza Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Influenza Vaccine Value Chain Analysis
  2. 12.1.1 Influenza Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Influenza Vaccine Production Mode & Process
  7. 12.2 Influenza Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Influenza Vaccine Distributors
  10. 12.2.3 Influenza Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst